Caffeine and the Autonomic Nervous System

Last updated: March 4, 2026
Sponsor: LMU Klinikum
Overall Status: Completed

Phase

N/A

Condition

N/A

Treatment

caffeine

Clinical Study ID

NCT04886869
CaffeineLMU
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Caffeine consumption has been linked to dysfunction of the autonomic nervous system. In this study the investigators analyze the effects of caffeine containing drinks (including energy drinks and coffee) on ECG based parameters of the autonomic nervous system.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • healthy individuals

  • > 18 years

Exclusion

Exclusion Criteria:

  • known cardiovascular disease

  • other diseases which may influence the autonomic nervous system

  • medication which may influence the autonomic nervous system

  • prior caffeine consumption (<24 hours)

Study Design

Total Participants: 20
Treatment Group(s): 1
Primary Treatment: caffeine
Phase:
Study Start date:
April 01, 2021
Estimated Completion Date:
June 30, 2021

Connect with a study center

  • University Hospital Munich (LMU Klinikum)

    Munich,
    Germany

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.